Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Gianfranco Ferraccioli, J. S. Smolen, P. Emery, W. Samborski, F. Berenbaum, O. R. Davies, W. Koetse, O. Purcaru, B. Bennett, H. Burkhardt

Risultato della ricerca: Contributo in rivistaArticolo in rivista

68 Citazioni (Scopus)

Fingerprint Entra nei temi di ricerca di 'Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial'. Insieme formano una fingerprint unica.

Medicine & Life Sciences